Drug Pricing in America: A Prescription for Change, Part II
Overflow room will be located in Dirksen 430.
- Ron Wyden (D - OR)
- Chuck Grassley (R - IA)
Chairman and Chief Executive OfficerAbbVie Inc.North Chicago , IL
Executive Director and Chief Executive OfficerAstraZenecaWilmington , DE
Chairman of the Board and Chief Executive OfficerBristol-Myers Squibb Co.New York , NY
Executive Vice President, Worldwide Chairman, Janssen PharmaceuticalsJohnson & JohnsonNew Brunswick , NJ
Chairman and Chief Executive OfficerMerck & Co., Inc.Kenilworth , NJ
Bourla, DVM, Ph.D.
Chief Executive OfficePfizerNew York , NY
Chief Executive OfficerSanofiBridgewater , NJ
How do I submit a statement for the record?
Any individual or organization wanting to present their views for inclusion in the hearing record should submit in a Word document, a single-spaced statement, not exceeding 10 pages in length. No other file type will be accepted for inclusion. Title and date of the hearing, and the full name and address of the individual or organization must appear on the first page of the statement. Statements must be received no later than two weeks following the conclusion of the hearing.
Statements can be emailed to:
Statements should be mailed (not faxed) to:
Senate Committee on Finance
Attn. Editorial and Document Section
Dirksen Senate Office Bldg.
Washington, DC 20510-6200